Full text is available at the source.
Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4–NF-κB Pathway
Tanshinone IIA reduces inflammation in immune cells by affecting gene regulators and the TLR4-NF-κB signaling pathway
AI simplified
Abstract
Tanshinone IIA could reduce cytokine production, including tumor necrosis factor alpha (TNF-α), in LPS-induced RAW264.7 cells.
- Tan IIA may inhibit the inflammatory response by decreasing levels of several inflammatory markers.
- Significant reductions in messenger RNA (mRNA) expressions of IL-1β, TNF-α, and COX-2 were noted with Tan IIA treatment.
- Tan IIA could diminish the activation of a specific signaling pathway (TLR4-MyD88-NF-κB) associated with inflammation.
- Expression levels of various microRNAs were altered by Tan IIA, indicating potential regulatory effects on gene expression.
- LPS treatment was associated with increased expression of certain microRNAs, which were decreased by Tan IIA.
AI simplified